ApoE4-dependent Abeta-mediated neurodegeneration is associated with inflammatory activation in the hippocampus but not the septum - PubMed (original) (raw)
. 2009 Nov;116(11):1427-34.
doi: 10.1007/s00702-009-0218-9. Epub 2009 Apr 16.
Affiliations
- PMID: 19370389
- DOI: 10.1007/s00702-009-0218-9
ApoE4-dependent Abeta-mediated neurodegeneration is associated with inflammatory activation in the hippocampus but not the septum
Haim Belinson et al. J Neural Transm (Vienna). 2009 Nov.
Abstract
Apolipoprotein E4 (ApoE4), the most prevalent genetic risk factor for Alzheimer's disease, is histopathologically associated with increased deposition of amyloid-beta and brain inflammation and with impaired neuronal plasticity and repair. We have recently shown that the activation of the amyloid cascade by inhibition of the Abeta-degrading enzyme, neprilysin, stimulates the isoform-specific degeneration of hippocampal CA1 neurons and septal neurons in apoE4 transgenic mice and that this effect is accompanied by the accumulation of intracellular Abeta in the affected neurons. We presently examined the extent to which this apoE4-dependent Abeta-mediated neurodegeneration is associated with brain area specific inflammatory activation. This revealed that the activation of the amyloid cascade in apoE transgenic mice results in the activation of microgliosis and astrogliosis in the hippocampus of apoE4, but not in apoE3 transgenic mice. The effect was most pronounced in the hippocampal CA1 subfield and its initial kinetics followed that of the accumulation of Abeta in CA1 neurons. In contrast, the corresponding apoE4-dependent Abeta degeneration of septal neurons was not associated with the activation of either gliosis or astrogliosis in this brain area. These animal model findings, that the association between brain inflammation and neurodegeneration is brain area specific, suggest that neuropathological inflammatory interactions in AD may also be brain area specific and that consequently the efficacy of putative anti-inflammatory intervention may also be brain area selective.
Similar articles
- Activation of the amyloid cascade in apolipoprotein E4 transgenic mice induces lysosomal activation and neurodegeneration resulting in marked cognitive deficits.
Belinson H, Lev D, Masliah E, Michaelson DM. Belinson H, et al. J Neurosci. 2008 Apr 30;28(18):4690-701. doi: 10.1523/JNEUROSCI.5633-07.2008. J Neurosci. 2008. PMID: 18448646 Free PMC article. - Human apoE3 but not apoE4 rescues impaired astrocyte activation in apoE null mice.
Ophir G, Meilin S, Efrati M, Chapman J, Karussis D, Roses A, Michaelson DM. Ophir G, et al. Neurobiol Dis. 2003 Feb;12(1):56-64. doi: 10.1016/s0969-9961(02)00005-0. Neurobiol Dis. 2003. PMID: 12609489 - Human apolipoprotein E redistributes fibrillar amyloid deposition in Tg-SwDI mice.
Xu F, Vitek MP, Colton CA, Previti ML, Gharkholonarehe N, Davis J, Van Nostrand WE. Xu F, et al. J Neurosci. 2008 May 14;28(20):5312-20. doi: 10.1523/JNEUROSCI.1042-08.2008. J Neurosci. 2008. PMID: 18480287 Free PMC article. - The nucleation growth and reversibility of Amyloid-beta deposition in vivo.
Dolev I, Michaelson DM. Dolev I, et al. J Alzheimers Dis. 2006 Nov;10(2-3):291-301. doi: 10.3233/jad-2006-102-313. J Alzheimers Dis. 2006. PMID: 17119294 Review. - Soluble apoE/Aβ complex: mechanism and therapeutic target for APOE4-induced AD risk.
Tai LM, Mehra S, Shete V, Estus S, Rebeck GW, Bu G, LaDu MJ. Tai LM, et al. Mol Neurodegener. 2014 Jan 4;9:2. doi: 10.1186/1750-1326-9-2. Mol Neurodegener. 2014. PMID: 24386905 Free PMC article. Review.
Cited by
- Microglia in Alzheimer Disease: Well-Known Targets and New Opportunities.
Hemonnot AL, Hua J, Ulmann L, Hirbec H. Hemonnot AL, et al. Front Aging Neurosci. 2019 Aug 30;11:233. doi: 10.3389/fnagi.2019.00233. eCollection 2019. Front Aging Neurosci. 2019. PMID: 31543810 Free PMC article. Review. - Potential mechanisms underlying lithium treatment for Alzheimer's disease and COVID-19.
Wei HF, Anchipolovsky S, Vera R, Liang G, Chuang DM. Wei HF, et al. Eur Rev Med Pharmacol Sci. 2022 Mar;26(6):2201-2214. doi: 10.26355/eurrev_202203_28369. Eur Rev Med Pharmacol Sci. 2022. PMID: 35363371 Free PMC article. Review. - Involvement of the Apoer2 and Lrp1 receptors in mediating the pathological effects of ApoE4 in vivo.
Gilat-Frenkel M, Boehm-Cagan A, Liraz O, Xian X, Herz J, Michaelson DM. Gilat-Frenkel M, et al. Curr Alzheimer Res. 2014;11(6):549-57. doi: 10.2174/1567205010666131119232444. Curr Alzheimer Res. 2014. PMID: 24251389 Free PMC article. - Effects of apoE deficiency and occlusal disharmony on amyloid-beta production and spatial memory in rats.
Ekuni D, Endo Y, Tomofuji T, Azuma T, Irie K, Kasuyama K, Morita M. Ekuni D, et al. PLoS One. 2013 Sep 16;8(9):e74966. doi: 10.1371/journal.pone.0074966. eCollection 2013. PLoS One. 2013. PMID: 24066161 Free PMC article. - ApoE4 induces synaptic and ERG impairments in the retina of young targeted replacement apoE4 mice.
Antes R, Ezra-Elia R, Weinberger D, Solomon A, Ofri R, Michaelson DM. Antes R, et al. PLoS One. 2013 May 31;8(5):e64949. doi: 10.1371/journal.pone.0064949. Print 2013. PLoS One. 2013. PMID: 23741431 Free PMC article.
References
- J Neurosci. 1997 Jan 15;17(2):516-29 - PubMed
- Neurobiol Dis. 2006 Apr;22(1):187-98 - PubMed
- J Alzheimers Dis. 2009;17(3):469-81 - PubMed
- J Mol Neurosci. 2004;23(3):205-12 - PubMed
- Acta Neuropathol. 1999 Sep;98(3):273-80 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous